# Equity Residential Common Shares of Beneficial Interest (EQR) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $63.66, market value $24.6 billion.

## Valuation
- **P/E (trailing): 28.7×** (5-yr avg 23.3×, 3-yr avg 23.4×). Equity Residential Common Shares of Beneficial Interest trades at 28.7× trailing earnings, well above its own five-year average of 23.3×: investors are paying up relative to the company's past. The Real Estate median in the September 2026 study was 25.2×. Forward P/E is 41.1×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 5.08**. A PEG of 5.08 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 7.9×**. Each dollar of revenue is priced at 7.9×.
- **Price / book: 2.3×**. The shares trade at 2.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 14.6×**. Enterprise value is 14.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 4.8%** (5-yr avg 5.5%). Free cash flow equals 4.8% of the market value, in line with its five-year average of 5.5%.
- **Earnings yield: 3.5%**. The inverse of the P/E: 3.5% of the price is earned each year.

## Profitability
- **Gross margin: 62.3%**. Equity Residential Common Shares of Beneficial Interest keeps 62.3% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 28.2%**. 28.2% of revenue is left after running the business, an exceptional level.
- **Net margin: 36.2%**. 36.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.1%**. 10.1% on shareholders' equity is solid.
- **Return on invested capital: 4.6%**. Return on all capital, debt included, is 4.6%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 4.2%**. Each dollar of assets produces 4.2% of profit.

## Growth
- **Revenue growth (1 yr): 3.8%** (3-yr 4.2%/yr). Revenue grew 3.8% over the last year.
- **EPS growth (1 yr): 8.1%** (3-yr 12.8%/yr, 5-yr 3.7%/yr). Earnings per share rose 8.1%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 1.8%/yr**. Free cash flow has compounded at 1.8% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.75**. Debt is 0.75 times equity, moderate leverage.
- **Net debt / EBITDA: 3.6×**. It would take 3.6 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: 2.8×**. Operating profit covers interest 2.8×, thin but manageable.
- **Altman Z-score: 2.61**. A Z-score of 2.61 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 4.26%** ($2.79 per share, trailing). Equity Residential Common Shares of Beneficial Interest yields 4.26%, an income-level yield.
- **Payout ratio: 93%** (88% of free cash flow). 93% of earnings goes out as dividends, leaving a thin cushion.
- **Consecutive years of increases: 1**. 1 straight year of increases.
- **Dividend growth (5 yr): 2.7%/yr** (1-yr 36.0%). The dividend has grown 2.7% a year over five years.

## Analyst view
- **Analyst consensus: buy** (17 analysts). 17 analysts cover Equity Residential Common Shares of Beneficial Interest; the consensus is buy, with an average price target of $72.99 (+15% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 3.8%** (YTD 4.4%, 3-mo -1.7%). The shares are up 3.8% over twelve months including dividends.
- **From 52-week high: -11.0%** (10.6% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 36**. An RSI of 36 is neutral.
- **Beta (1 yr): 0.18** (volatility 20%). Beta of 0.18 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=EQR · Page: https://foliofundamentals.com/stocks/eqr

Not investment advice.
